| Place of Origin: | China |
|---|---|
| Brand Name: | Senwayer Brand |
| Certification: | ISO, 9001, USP |
| Model Number: | 184475-35-2 |
| Minimum Order Quantity: | 10g |
| Price: | Discount is possible if your order is big enough |
| Packaging Details: | 10g, 20g, 50g , 100g, 500g. 1kg, 10kg |
| Delivery Time: | within 2 working days |
| Payment Terms: | T/T in advance, Money Gram, Western Union, Bank Transfer. |
| Supply Ability: | 50KG / Month |
| CAS: | 184475-35-2 | Apparence: | White Crystalline Powder |
|---|---|---|---|
| Purity: | 99% | Other Name: | Gefitinib, Iressa |
| Stock: | Available | Grade: | Pharma Grade |
| High Light: | pharmaceutical raw material,chemical raw material |
||
Legal Gefitinib Iressa CAS 184475-35-2 Pharmaceutical Cancer Treating Raw Material
Quick detail
| Name: | Gefitinib |
| CAS No.: | 184475-35-2 |
| Formula: | C22H24ClFN4O3 |
| Molecular Weight: | 446.90 . |
| Synonyms: | N-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;ZD1839;4-(3-Chloro-4-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline; Irressat;Gefitinib (JAN/USAN);4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-;ZD 1839;4-Quinazolinamine, |
| Density: | 1.322 g/cm3 |
| Melting Point: | 119-120 °C |
| Boiling Point: | 586.8 °C at 760 mmHg |
| Flash Point: | 308.7 °C |
| Appearance: | light-yellow crystalline powder |
Recommended Antineoplastic products
| Lapatinib | CAS : 231277-92-2 | Cisplatin | 15663-27-1 |
| Dasatinib | 302962-49-8 | Vincristine sulfate | 2068-78-2 |
| Axitinib | 319460-85-0 | Melphalan | 148-82-3 |
| Gefitinib | 184475-35-2 | Nimustine hydrochloride | 55661-38-6 |
| Sunitinib Malate | 341031-54-7 | Gemcitabine | 95058-81-4 |
| Erlotinib hydrochloride | 183319-69-9 107868-30-4 | Paclitaxel | 33069-62-4 |
| Doxorubicin hydrochloride | 25316-40-9 | Docetaxel | 114977-28-5 |
| Mitomycin C | 50-07-7 | (Podophyllotoxin)nsc24818 | 518-28-5
Recommended Antineoplastic products: |
| Tegafur | 17902-23-7 |
Gefitinib Description :
Gefitinib is a type of drug called a tyrosine kinase inhibitor (TKI), also known as a cancer growth inhibitor. Kinases are proteins in the body that regulate how the cells grow and divide. Gefitinib blocks (inhibits) the protein from sending signals to the cancer cells that make them grow and divide.
For the treatment of locally advanced or metastatic non-small cell lung cancer, after failure of both platinum-based and taxane-based chemotherapies.
Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.
Taking gefitinib
Gefitinib is taken as a tablet once a day, about the same time each day. Take the tablet with a glass of water, with or without food.
If you have trouble swallowing tablets put the tablet in a glass of water and leave it to dissolve. It may take 20 minutes to completely dissolve. Once it’s dissolved, drink it straight away then refill the glass with water and drink it to make sure you’ve taken all of the gefitinib.
Always take your tablets exactly as your nurse or pharmacist explained. This is important to make sure they work as well as possible for you.
There are some important things to remember when taking your tablets:
Possible side effects of gefitinib
Gefitinib COA
Tests |
Specification |
Results |
Appearance |
Slight white to white crystalline powder |
White crystalline powder |
Identification IR(1) |
Conforms to the refence |
Conforms to the refence |
Melting Point |
194.0~198.0°C |
196.0~197.0°C |
Water(KF) |
≤0.30% |
0.05% |
Assay (HPLC) |
≥99.0% |
99.9% |
Individual Purity (HPLC ) |
≤0.20% |
0.09% |
Conclusion |
Conform with company standard |
|
